Newsroom
Sorted by: Latest
-
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke (AIS), today announced that it has received a No Objection Letter (NOL) from Health Canada for its Clinical Trial Application to evaluate DM199 in a Phase 2 trial in patients with early-onset preeclampsia (PE). This regulatory clearance enables DiaMedica to initiate its Pha...
-
GeoPark Announces Strategic Investment by Grupo Gilinski to Accelerate Long-term Growth Strategy
BOGOTA, Colombia--(BUSINESS WIRE)--GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent energy company with over 20 years of successful operations across Latin America, today announced a strategic private investment in public equity (PIPE) transaction with Colden Investments S.A. (“Colden”), an affiliate of Jaime Gilinski, who leads one of Latin America’s most diversified global investment groups (“Grupo Gilinski”). The investment was led by Jaime and Gabriel Gilinsk...
-
Suffolk Taps Industry Veteran Louis Martinelli to Scale Its Freedom Source Supply Chain Vertical and Reinforce Its Seamless Platform Delivery
BOSTON--(BUSINESS WIRE)--Suffolk, one of the most innovative and successful builders in the country, today announced Louis Martinelli’s hiring as Head of Freedom Source, the company’s direct-to-manufacturer procurement engine designed to increase cost transparency and competitive pricing, improve supply reliability, and streamline the design-to-construction workflow for clients. He will report directly to Pat Lucey, President of Suffolk Northeast and National Centers of Excellence. In his new r...
-
Apollo Global Management, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – APO
LOS ANGELES--(BUSINESS WIRE)--Apollo Global Management, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – APO...
-
Distribution Solutions Group Announces 2025 Full Year and Fourth Quarter Results
FORT WORTH, Texas--(BUSINESS WIRE)--Distribution Solutions Group, Inc. (NASDAQ:DSGR) ("DSG" or the "Company"), a premier specialty distribution company, today announced consolidated results for the fourth quarter ended December 31, 2025. This press release is supplemented by an earnings presentation at https://investor.distributionsolutionsgroup.com/news/events. The following represents a summary of certain operating results (unaudited). See the reconciliations of GAAP to non-GAAP measures in T...
-
ProCap Financial Continues to Gobble up Shares at a Discount to NAV
NEW YORK--(BUSINESS WIRE)--ProCap Financial, Inc. (Nasdaq: BRR), the first publicly traded agentic finance firm, today announced it repurchased 196,043 shares of its common stock in the open market yesterday. "Every day feels like Christmas morning when the market is willing to sell you shares of your own company below NAV," said Anthony Pompliano, Chairman and CEO of ProCap Financial. “We will keep buying and buying and buying!” About ProCap Financial ProCap Financial is the first publicly tra...
-
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
LONDON--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq: SLN, a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided an update on recent business achievements. “The past year was focused on clinical execution, demonstrated by the expedited enrollment in the Phase 2 SANRECO trial of divesiran in PV which is on-track for topline results in third quarter...
-
Ranpak Holdings Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
CONCORD TOWNSHIP, Ohio--(BUSINESS WIRE)--Ranpak Holdings Corp. Reports Fourth Quarter and Full Year 2025 Financial Results...
-
Ambiq Reports Fourth Quarter and Full Year 2025 Financial Results
AUSTIN, Texas--(BUSINESS WIRE)--Ambiq Micro, Inc. (“Ambiq”) (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced financial results for the fourth quarter and full year 2025. Full Year 2025 and Recent Highlights Strong performance on accelerating demand for edge AI solutions: Fourth quarter net sales were ahead of guidance with sequential net sales growth in every quarter of 2025. Continued AI-driven margin expansion: Delivered year-over-year...
-
LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform for AI-Driven Laboratory Operations
SOMERSET, N.J.--(BUSINESS WIRE)--75% of labs are adopting AI. Is yours? LabVantage CORTEX delivers a customer-centric AI ecosystem to improve efficiency, accuracy and data insights....